Join
Live feed
·
INSIDERFilingvia Quantisnow
Day One Biopharmaceuticals Inc. logo

Director Holles Natalie C. returned 57,310 shares to the company, closing all direct ownership in the company (SEC Form 4) to satisfy tax liability

ByQuantisnow·Wall Street's wire, on your screen.
DAWN· Day One Biopharmaceuticals Inc.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track DAWN (Day One Biopharmaceuticals Inc.) and more on Quantisnow.